Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
US Market
Holding GRCL?
Track your performance easily

Gracell Biotechnologies (GRCL) Cash flow

134 Followers

Gracell Biotechnologies Cash Flow

GRCL's free cash flow for Q4 2022 was $―. For the 2022 fiscal year, GRCL's free cash flow was decreased by $-20.30M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
-$ -69.98M$ -47.79M$ -198.15M$ -135.39M$ -61.86M
Investing Cash Flow
-$ -7.01M$ -6.53M$ -93.94M$ 41.37M$ -113.36M
Financing Cash Flow
-$ 4.83M$ 228.51M$ 756.47M$ 394.80M$ 138.69M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-$ 210.90M$ 287.01M$ 754.31M$ 312.06M$ 11.89M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-$ 977.00K$ 795.00K$ 2.15M$ 0.00$ 0.00
Issuance Of Capital Stock
---$ 795.42M$ 439.50M$ 0.00
Issuance Of Debt
-$ 5.24M$ 3.13M$ 103.01M$ 0.00$ 148.69M
Repayment Of Debt
-$ -9.93M$ -8.05M$ -138.82M$ 0.00$ -10.00M
Free Cash Flow
-$ -76.99M$ -56.70M$ -277.55M$ -191.82M$ -73.21M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Gracell Biotechnologies Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis